Clinical trial
Clinical Evaluation of the xMAP® NeoPlex4™ Assay for Detection of T4, TSH, 17-OHP and IRT Using the NeoPlex System
NCT01488721 is registered in ClinicalTrials.gov with Luminex Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the xMAP® NeoPlex4™ Assay for Detection of T4, TSH, 17-OHP and IRT Using the NeoPlex System
- Lead sponsor
- Luminex Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- April 30, 2012
- Enrollment
- 7,462 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.